
    
      Patients with congestive heart failure, grade 3-4, in addition to the standard care, will be
      randomized 1:1. The study group will receive 2 doses of IV iron (Iron carboxymaltose). The
      control group will receive standard of care alone. The study will test for the effects of the
      additional IV iron on the symptoms, clinical picture and quality of life of the treated
      patients. The parameters that will be measured will include clinical, lab, echo, and quality
      of life questionnaires.
    
  